Dazopride is an investigational pharmaceutical compound primarily studied for its effects on the gastrointestinal system. It functions as a prokinetic agent, enhancing motility in the digestive tract, which shows potential in treating conditions such as gastroparesis and other motility disorders. Additionally, it has been investigated for antiemetic properties to alleviate nausea and vomiting, particularly in chemotherapy patients or those with postoperative nausea. Its mechanism of action involves modulation of serotonin (5-HT4) receptors, which are crucial for gut motility and the emetic reflex. Research is ongoing to evaluate its efficacy and safety in gastrointestinal and related applications. Note: Dazopride is not currently approved for clinical use.